OPTR Headlines | Optimer Pharmaceuticals, Inc. Stock - Yahoo! Finance

Mon, May 20, 2013, 3:33AM EDT - U.S. Markets open in 5 hrs 57 mins

Dow

0.80% Nasdaq

0.97%

More On OPTR

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Optimer Pharmaceuticals, Inc. (OPTR)

-NasdaqGS

14.97 May 17, 4:00PM EDT

Add to Portfolio

Headlines

Get Headlines for:

Wednesday, March 6, 2013

Why Optimer Pharmaceuticals Is Poised to Pull Backat Motley Fool (Wed, Mar 6)

Monday, March 4, 2013

Optimer Posts Wider LossZacks (Mon, Mar 4)
This Week in Biotechat Motley Fool (Mon, Mar 4)

Saturday, March 2, 2013

New Star Analyst Rankings for Optimer Pharmaceuticals, Inc.StarMine (Sat, Mar 2)

Friday, March 1, 2013

3 Humongous Health-Care Stocks This Weekat Motley Fool (Fri, Mar 1)
Encouraging News for Cubist PharmaZacks (Fri, Mar 1)
Optimer Pharmaceuticals Beats on Both Top and Bottom Linesat Motley Fool (Fri, Mar 1)

Thursday, February 28, 2013

Optimer Pharmaceuticals Management Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Thu, Feb 28)
Optimer Pharmaceuticals Earnings: Everything You Must Know Nowat Wall St. Cheat Sheet (Thu, Feb 28)
OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, FinanciaEDGAR Online (Thu, Feb 28)
Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial ResultsPR Newswire (Thu, Feb 28)
Pandora Still a Strong Outperform and 4 Analyst Notes to Knowat Wall St. Cheat Sheet (Thu, Feb 28)
Q4 2012 Optimer Pharmaceuticals Inc Earnings Release - After Market CloseCCBN (Thu, Feb 28)

Wednesday, February 27, 2013

Can Optimer Optimize Shareholder Returns?at Motley Fool (Wed, Feb 27)
OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations andEDGAR Online (Wed, Feb 27)
Cave Explorer Hunts Antibiotics 1,600 Feet Down: Healthat Bloomberg (Wed, Feb 27)
Optimer Consider Strategic Alternatives as CEO Steps Downat Bloomberg (Wed, Feb 27)
3 Biotech Stocks Rising on Big Volumeat TheStreet (Wed, Feb 27)
Why Optimer Pharmaceuticals Shares Soaredat Motley Fool (Wed, Feb 27)
Optimer Pharma exploring sale, shares jumpat Reuters (Wed, Feb 27)
Optimer board to review strategic alternativesAP (Wed, Feb 27)
Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire (Wed, Feb 27)
Optimer as adopted a Rights Plan that expires February 15, 2014theflyonthewall.com (Wed, Feb 27)
Optimer announced it will begin to explore full range of strategic alternativestheflyonthewall.com (Wed, Feb 27)
Optimer Pharmaceuticals' Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive OfficerPR Newswire (Wed, Feb 27)

Older Headlines - Most Recent Headlines

Add OPTR News to My Yahoo!

Copyright © 2009 Yahoo! All rights reserved.

Quotes are real-time for NASDAQ, NYSE, and NYSE MKT. See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.